Singh; Chandra U.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Singh; Chandra U..The latest application filed is for "solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening".

Company Profile

2.9.22

Singh; Chandra U. - San Antonio TX US
Singh; Chandra U. - Encinitas CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances with Reduced Ostwald Ripening App 20190110993 - Selvaraj; Raj ; et al.	2019-04-18
Solid Nanoparticle Formulation Of Microtuble Inhibitors With Reduced Ostwald Repening For Oral Administration App 20170020817 - Singh; Chandra U.	2017-01-26
Rapidly-dissolving Thin Film Formulation Of Water Soluble Digitalis Glycoside For The Treatment Of Congestive Heart Disease App 20160206641 - Singh; Chandra U.	2016-07-21
Method to treat premature ejaculation in humans Grant 9,272,037 - Singh March 1, 2	2016-03-01
Pharmaceutical Compositions For Treating Pain Associated With Dysmenorrhea App 20150313892 - Singh; Chandra U. ; et al.	2015-11-05
Method to Treat Premature Ejaculation in Humans App 20140296262 - Singh; Chandra U.	2014-10-02
Pharmaceutical Compositions Comprising Capsaicin Esters for Treating Pain and Cold Sores App 20140134261 - Singh; Chandra U. ; et al.	2014-05-15
Method to treat premature ejaculation in humans Grant 8,604,082 - Singh December 10, 2	2013-12-10
Novel Pharmaceutical Compositions for Treating Chronic Pain and Pain Associated with Neuropathy App 20130189354 - Singh; Chandra U.	2013-07-25
Pharmaceutical And Nutraceutical Compositions For Treating Respiratory Disease And Associated Phlegm App 20120121730 - Singh; Chandra U.	2012-05-17
Method for treatment of premature ejaculation in humans Grant 7,754,767 - Singh July 13, 2	2010-07-13
Novel Pharmaceutical Compositions For Treating Acquired Chronic Pain And Associated Dysphoria App 20090312361 - Streeper; Robert T. ; et al.	2009-12-17
Method to Treat Premature Ejaculation in Humans App 20090215810 - Singh; Chandra U.	2009-08-27
Novel Pharmaceutical Compositions for Treating Acquired Chronic Pain and Associated Dysphoria App 20080176873 - Streeper; Robert T. ; et al.	2008-07-24
Protein-Stabilized Liposomal Formulations of Pharmaceutical Agents App 20070166368 - Singh; Chandra U.	2007-07-19
Protein-stabilized liposomal formulations of pharmaceutical agents Grant 7,179,484 - Singh February 20, 2	2007-02-20
Topical and oral formulations of cardiac glycosides for treating skin diseases App 20060205679 - Streeper; Robert ; et al.	2006-09-14
Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases App 20050026849 - Singh, Chandra U. ; et al.	2005-02-03
Protein-stabilized liposomal formulations of pharmaceutical agents App 20040247660 - Singh, Chandra U.	2004-12-09
Method for treatment of premature ejaculation in humans App 20040235954 - Singh, Chandra U.	2004-11-25
Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases App 20040082521 - Singh, Chandra U.	2004-04-29
Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof Grant 6,565,897 - Selvaraj , et al. May 20, 2	2003-05-20
Extract Of Nerium Species, Pharmaceutical Composition Thereof And Methods For Preparation Thereof App 20020114852 - SELVARAJ, ULAGARAJ ; et al.	2002-08-22
Method of rational drug design based on ab initio computer simulation of conformational features of peptides Grant 5,612,895 - Balaji , et al. March 18, 1	1997-03-18
Method of rational drug design based on AB initio computer simulation of conformational features of peptides Grant 5,579,250 - Balaji , et al. * November 26, 1	1996-11-26
Method of design of compounds that mimic conformational features of selected peptides Grant 5,331,573 - Balaji , et al. July 19, 1	1994-07-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.